Search Browse Earnings

VYNE Therapeutics Inc. — SlamSEC

VYNE Therapeutics Inc.

Nasdaq:VYNE

Pharmaceutical Preparations·BRIDGEWATER, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$501,000

+18.2% YoY

FY 2025

Adj. EBITDA

-$43.6M

-8709.2% margin

FY 2025

Net Income

-$39.8M

-7950.9% margin

FY 2025

EPS (Diluted)

-$0.93

FY 2025

Stock Price

$0.59

+0.7%

2026-03-13

52W Range

$0.28 – $1.99

P/E Ratio

-0.6x

Market Cap

$19.7M

Cash

$19.9M

FY 2025

Total Debt

$33.2M

FY 2021

Net Debt

$13.2M

FY 2021

Enterprise Value

$33.0M

Debt / EBITDA

-0.3x

FY 2025

EV / EBITDA

-0.8x

Employees

—